May 6, 2022 7:00 am EDT Camille Schrier, Miss America 2020, and Castle Biosciences Partner to Expand Awareness of Genetic Testing in Depression and Anxiety
May 3, 2022 5:00 pm EDT Castle Biosciences Recognizes Skin Cancer Awareness Month through Its Support of Patient-Focused Initiatives
Apr 29, 2022 7:00 am EDT Castle Biosciences Announces Expanded U.S. Federal Supply Schedule Contract Covering Its Entire Dermatologic Cancer Portfolio of Tests
Apr 27, 2022 7:00 am EDT Data from Independent, Pooled Analysis Show Significantly Improved Risk Predictions Over Clinical Variables for TissueCypher® Barrett’s Esophagus Test and Ability to Identify Patients at High Risk of Progressing to Esophageal Cancer
Apr 25, 2022 5:00 pm EDT Castle Biosciences to Release First Quarter 2022 Financial Results and Host Conference Call on Monday, May 9
Apr 21, 2022 5:00 pm EDT Expanded SEER Registries Dataset Shows Improved Survival for DecisionDx®-Melanoma Tested Patients Compared to Untested Patients
Apr 20, 2022 5:00 pm EDT Castle Biosciences to Present Data at the 18th European Association of Dermato Oncology (EADO) Congress
Apr 18, 2022 7:00 am EDT Castle Biosciences Presents Data on Its Inflammatory Skin Disease Pipeline Test at the 4th Annual Revolutionizing Atopic Dermatitis (RAD) Conference
Apr 5, 2022 5:00 pm EDT Castle Biosciences to Present at the 21st Annual Needham Virtual Healthcare Conference
